Top 10 HealthCare Devices and Supplies Capital Raises and Investors in the U.S. – October 1st – 15th , 2025

Several interesting transactions closed in the HealthCare Devices and Supplies sector over the past two weeks. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.

PIPE

    1. Envoy Medical, a hearing health company that provides medical technologies, it is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life, received approximately $4 million of development capital.

Merger/Acquisition and Corporate

    1. BennuBio, a flow cytometer device that facilitates monitoring and analysis of blood cells and particles, acquired by Precision Cell Systems.
    2. Neuronoff, an injectable electrode platform that transforms complex neuromodulation surgeries into simple outpatient procedures, received $4.5 millions in financing.

Later Stage VC

    1. AtaCor Medical, cardiac pacing and defibrillation leads, and associated delivery tools that provides alternatives to traditional devices, raised $75 million of venture funding.
    2. Turner Innovations, X-ray imaging systems that capture full fluoroscopy function and radiography images, raised $1.24 million of venture funding from Ariel Savannah Angel Partners.
    3. Zuno Medical, an innovative technology that delivers efficiency and reliability to the steam sterilization process, raised $8.66 million of venture funding.

Early Stage VC

    1. Kilele Health, a remote patient monitoring device for chronic disease management. raised $264,500 of venture funding.
    2. AcQumen Medical, a non-invasive hemodynamic analytics tools that improves pediatric and neonatal critical care, raised a venture funding from Groove Capital.

Angel, Seed, and Grant

    1. Better Bionics, a prosthetic hand device that provides support to prosthetic patients, joined i.d.e.a. Fund as a part of its Cohort 4 and received $20,000 in funding.
    2. Aromha, an at-home brain health screening test that identifies early signs of cognitive decline via remote smell and olfactory assessment, raised $250,000 of seed funding.

#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcaredevicesandsupplies #healthcaredevice

Tamara Williams

Managing Director

Please contact me if you have any questions or would like to discuss your capital raise:

Email: twilliams@castleplacement.com

(C) (385) 600-1871

Send us a message:

Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.

CONTACT US

Hi. We're not around right now. But you can send us an email and we'll get back to you, asap.

Thanks, Ken

Ken Margolis | Managing Partner Castle Placement
1460 Broadway Street
New York, New York 10036
(212) 418-1180
kmargolis@castleplacement.com

Sending

Log in with your credentials

Forgot your details?